drugset / Trial / NCT00810524

Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection

NCT00810524

Phase 4 Unknown 600 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelTreatment

Summary

Influence of antiviral treatment to the long term prognosis of patients with chronic HBV infection. The aim of antiviral treatment for HBV is to reduce the long term severe complications. In this study, the investigators divided patients with chronic HBV infection into two groups, which start early antiviral treatment and conventional antiviral treatment respectively. All the patients will be followed for ten years. From this study, the investigators want to find out the optimal time for patients with chronic HBV infection to start antiviral treatment.

Timeline

Start
2007-01
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir dipivoxil Small molecule 10 mg Oral
Subject Enticavir Unknown 0.5 mg Oral
Subject Lamivudine Other / unclassified 100 mg Oral
Subject Telbivudine Small molecule 600 mg Oral